A Pilot Training Program for a Motivational Enhancement Approach to Hepatitis C Virus Treatment Among Individuals in Israeli Methadone Treatment Centers

REFERENCES

• Aceijas, C., & Rhodes, T. (2007). Global estimates of prevalence of HCV infection among injecting drug users. International Journal on Drug Policy, 18(5), 352–358.
   PubMed Web of Science ®Google Scholar
• Braddock, C. H., III, Edwards, K. A., Hasenberg, N. M., Laidley, T. L., & Levinson, W. (1999). Informed decision making in outpatient practice: Time to get back to basics. JAMA, 282(24), 2313–2320.
   PubMed Web of Science ®Google Scholar
• Brueck, R. K., Frick, K., Loessl, B., Kriston, L., Schondelmaier, S., Go, C., (2009). Psychometric properties of the German version of the motivational interviewing treatment integrity code. Journal of Substance Abuse Treatment, 36(1), 44–48.
   PubMed Web of Science ®Google Scholar
• Carels, R. A., Darby, L., Cacciapaglia, H. M., Konrad, K., Coit, C., Harper, J., (2007). Using motivational interviewing as a supplement to obesity treatment: A stepped-care approach. Health Psychology 26(3), 369–374.
   PubMed Web of Science ®Google Scholar
• Castonguay, L. G., Constantino, M. J., & Holtforth, M. G. (2006). The working alliance: Where are we and where should we go? Psychotherapy: Theory/Research/Practice/Training, 43(3), 271–279.
   PubMed Web of Science ®Google Scholar
• Channon, S. J., Huws-Thomas, M. V., Rollnick, S., Hood, K., Cannings-John, R. L., Rogers, C., (2007). A multicenter randomized controlled trial of motivational interviewing in teens with diabetes. Diabetes Care, 30(6), 1390–1395.
   PubMed Web of Science ®Google Scholar
• Chirkov, V., Ryan, R. M., Youngmee, K., & Kaplan, U. (2003). Differentiating autonomy from individualism and independence: A self-determination theory perspective on internalization of cultural orientations and well-being. Journal of Personality and Social Psychology, 84(1), 97–110.
   PubMed Web of Science ®Google Scholar
• Cohen-Moreno, R., Schiff, M., Levitt, S., Bar-Hamburger, R., Strauss, S., & Neumark, Y. (2010). Knowledge about hepatitis-C among methadone maintenance treatment patients in Israel. Substance Use & Misuse, 45(1–2), 58–76.
   PubMed Web of Science ®Google Scholar
• Crockett, B., & Gifford, S. M. (2004). “Eyes wide shut”: Narratives of women living with hepatitis C in Australia. Women and Health, 39(4), 117–137.
   PubMed Web of Science ®Google Scholar
• Deci, E. L., Eghrari, H., Patrick, B. C., & Leone, D. R. (1994). Facilitating internalization: The self-determination theory perspective. Journal of Personality, 62(1), 119–142.
   PubMed Web of Science ®Google Scholar
• Deutsch, M., & Hadziyannis, S. J. (2008). Old and emerging therapies in chronic hepatitis C: An update. Journal of Viral Hepatitis, 15(1), 2–11.
   PubMed Web of Science ®Google Scholar
• Doab, A., Treloar, C., & Dore, G. J. (2005). Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clinical Infectious Diseases, 40(5 Suppl.), S313–S320.
   Google Scholar
• Dore, G. J., Law, M., MacDonald, M., & Kaldor, J. M. (2003). Epidemiology of hepatitis C virus infection in Australia. Journal of Clinical Virology, 26(2), 171–184.
   PubMed Web of Science ®Google Scholar
• Edlin, B. R., Kresina, T. F., Raymond, D. B., Carden, M. R., Gourevitch, M. N., Rich, J. D., (2005). Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clinical Infectious Diseases, 40(5 Suppl.), S276–S285.
   Google Scholar
• Epelboym, R. (1995). Motivational interviewing: Theory and practice. Society and Welfare, 15(2–3), 317–326.
   Google Scholar
• Evon, D., Simpson, K., Esserman, D., Verma, V., Smith, S., & Fried, M. (2010). Barriers to accessing care in patients with chronic Hepatitis C: The impact of depression. Aliment Pharmacol Theraputics, 32(9), 1163–1173.
   PubMed Web of Science ®Google Scholar
• Fife, B. L., & Wright, E. R. (2000). The dimensionality of stigma: A comparison of its impact on the self of persons with HIV/AIDS and cancer. Journal of Health and Social Behavior, 41(1), 50–67.
   PubMed Web of Science ®Google Scholar
• Fischer, B., Kalousek, K., Rehm, J., Powis, J., Krajden, M., & Reimer, J. (2006). Hepatitis C, illicit drug use and public health: Does Canada really have a viable plan? Canadian Journal of Public Health Revue Canadienne De Sante Publique, 97(6), 485–488.
   PubMed Web of Science ®Google Scholar
• Fishbein, D. A., Lo, Y., Reinus, J. F., Gourevitch, M. N., & Klein, R. S. (2004). Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999), 37(3), 1367–1375.
   PubMed Web of Science ®Google Scholar
• Fraenkel, L., McGraw, S., Wongcharatrawee, S., & GarciaTsao, G. (2006). Patients’ experiences related to anti-viral treatment for hepatitis C. Patient Education and Counseling, 62(1), 148–155.
   PubMed Web of Science ®Google Scholar
• Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Jr., (2002). Peg interferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. New England Journal of Medicine, 347(13), 975–982.
   PubMed Web of Science ®Google Scholar
• Friedman, A. M., & Marchevsky, A. (1995). No deductions: Enhancing motivation for cooperation in a relapse prevention group. Society and Welfare, 15(2–3), 327–336.
   Google Scholar
• George, S. L., Bacon, B. R., Brunt, E. M., Mihindukulasuriya, K. L., Hoffmann, J., & Di Bisceglie, A. M. (2009). Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients. Hepatology, 49(3), 729–738.
   PubMed Web of Science ®Google Scholar
• Grebely, J., Genoway, K. A., Raffa, J. D., Dhadwal, G., Rajan, T., Showler, G., (2008). Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug and Alcohol Dependence, 93(1–2), 141–147.
   PubMed Web of Science ®Google Scholar
• Groessl, E. J., Weingart, K. R., Kaplan, R. M., Clark, J. A., Gifford, A. L., & Ho, S. B. (2008). Living with hepatitis C: Qualitative interviews with hepatitis C-infected veterans. Journal of General Internal Medicine, 23(12), 1959–1965.
   PubMed Web of Science ®Google Scholar
• Hallinan, R., Byrne, A., Agho, K., & Dore, G. J. (2007). Referral for chronic hepatitis C treatment from a drug dependency treatment setting. Drug and Alcohol Dependence, 88(1), 49–53.
   PubMed Web of Science ®Google Scholar
• Julius, R. J., Novitsky, M. A., Jr., & Dubin, W. R. (2009). Medication adherence: A review of the literature and implications for clinical practice. Journal of Psychiatric Practice, 15(1), 34–44.
   PubMed Web of Science ®Google Scholar
• Kennedy, S., Goggin, K., & Nollen, N. (2004). Adherence to HIV medications: Utility of the theory of self-determination. Cognitive Therapy and Research, 28(5), 611–628.
   Web of Science ®Google Scholar
• Khokhar, O. S., & Lewis, J. H. (2007). Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: Do they alter their decision with time? Digestive Diseases and Sciences, 52(5), 1168–1176.
   PubMed Web of Science ®Google Scholar
• Lavanchy, D. (2009). The global burden of hepatitis C. Liver International, 29(1 Suppl.), 74–81.
   PubMedGoogle Scholar
• Levesque, C. S., Williams, G. C., Elliot, D., Pickering, M. A., Bodenhamer, B., & Finley, P. J. (2007). Validating the theoretical structure of the treatment self-regulation questionnaire (TSRQ) across three different health behaviors. Health Education Research, 22(5), 691–702.
   PubMed Web of Science ®Google Scholar
• Litwin, A. H., Kunins, H. V., Berg, K. M., Federman, A. D., Heavner, K. K., Gourevitch, M. N., (2007). Hepatitis C management by addiction medicine physicians: Results from a national survey. Journal of Substance Abuse Treatment, 33, 99–105.
   PubMed Web of Science ®Google Scholar
• Loebstein, R., Mahagna, R., Maor, Y., Kurnik, D., Elbaz, E., Halkin, H., (2008). Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: Prevalence and risk factors. Israel Medical Association Journal, 10, 775–778.
   PubMed Web of Science ®Google Scholar
• Loguercio, C., Di Pierro, M., Di Marino, M. P., Federico, A., Disalvo, D., Crafa, E., (2000). Drinking habits of subjects with hepatitis C virus-related chronic liver disease: Prevalence and effect on clinical, virological and pathological aspects. Alcohol and Alcoholism, 35(3), 296–301.
   PubMed Web of Science ®Google Scholar
• Malnick, S. D., Sheidvasser, V., Basevitz, A., & Levit, S. (2009). A model for treating HCV hepatitis in patients receiving methadone maintenance therapy. Gastroenterology, 136(5), A831.
   Web of Science ®Google Scholar
• Marcellin, P. (2009). Hepatitis B and hepatitis C in 2009. Liver International, 29(1 Suppl.), 1–8.
   PubMedGoogle Scholar
• McCarthy, J. J., & Flynn, N. (2001). Hepatitis C in methadone maintenance patients: Prevalence and public policy implications. Journal of Addictive Diseases, 20(1), 19–31.
   PubMed Web of Science ®Google Scholar
• Miller, W. R. (1983). Motivational interviewing with problem drinkers. Behavioural Psychotherapy, 11(2), 147–172.
   Web of Science ®Google Scholar
• Miller, W. R., & Brown, J. M. (1991). Self-regulation as a conceptual basis for the prevention and treatment of addictive behaviours. In N. Heather, W. R. Miller, & J. Greeley (Eds.), Self-control and the addictive behaviours (pp. 3–79). Sydney: Maxwell Macmillan.
   Google Scholar
• Miller, W. R., & Mount, K. A. (2001). A small study of training in motivational interviewing: Does one workshop change clinician and client behavior? Behavioural and Cognitive Psychotherapy, 29(4), 457–471.
   Web of Science ®Google Scholar
• Miller, W. R., & National Institute on Drug Abuse. (1995). Motivational enhancement therapy with drug abusers. [s.l.]: [University of New Mexico Press].
   Google Scholar
• Miller, W. R., & Rollnick, S. (2002). Motivational interviewing, second edition: Preparing people for change (2nd ed.). New York: Guilford Press.
   Google Scholar
• Miller, W. R., Villanueva, M., Tonigan, J. S., & Cuzmar, I. (2007). Are special treatments needed for special populations? Alcoholism Treatment Quarterly, 25(4), 63–78.
   Google Scholar
• Narasimhan, G., Sargios, T. N., Kalakuntla, R., Homel, P., Clain, D. J., Theise, N. D., (2006). Treatment rates in patients with chronic hepatitis C after liver biopsy. Journal of Viral Hepatitis, 13(11), 783–786.
   PubMed Web of Science ®Google Scholar
• O'Brien, S., Day, C., Black, E., & Dolan, K. (2008). Injecting drug users’ understanding of hepatitis C. Addictive Behaviors, 33, 1602–1605.
   PubMed Web of Science ®Google Scholar
• Parsons, J. T., Golub, S. A., Rosof, E., & Holder, C. (2007). Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: A randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes, 46(4), 443–450.
   PubMed Web of Science ®Google Scholar
• Peles, E., Linzy, S., Kreek, M. J., & Adelson, M. (2008). One-year and cumulative retention as predictors of success in methadone maintenance treatment: A comparison of two clinics in the United States and Israel. Journal of Addictive Diseases, 27(4), 11–25.
   PubMed Web of Science ®Google Scholar
• Roth, G., Assor, A., Kanat-Maymon, Y., & Kaplan, H. (2006). Assessing the experience of autonomy in new cultures and contexts. Motivation and Emotion, 30, 365–376.
   Web of Science ®Google Scholar
• Rounsaville, B. J., Carroll, K. M., & Onksen, L. S. (2001). A stage model of behavioral therapies research: Getting started and moving on from stage 1. Clinical Psychology Science and Practice, 8, 133–142.
   Web of Science ®Google Scholar
• Ryan, R. M., & Deci, E. L. (2008). A self-determination theory approach to psychotherapy: The motivational basis for effective change. Canadian Psychology, 49(3), 186–193.
   Web of Science ®Google Scholar
• Shanahan, C. W., Beers, D., Alford, D. P., Brigandi, E., & Samet, J. H. (2010). A transitional opioid program to engage hospitalized drug users. Journal of General Internal Medicine, 25(8), 803–808.
   PubMed Web of Science ®Google Scholar
• Shepard, C. W., Finelli, L., & Alter, M. J. (2005). Global epidemiology of hepatitis C virus infection. The Lancet Infectious Diseases, 5(9), 558–567.
   PubMed Web of Science ®Google Scholar
• Strathdee, S. A., Latka, M., Campbell, J., O'Driscoll, P. T., Golub, E. T., Kapadia, F., (2005). Factors associated with interest in initiating treatment for hepatitis C virus (HCV) infection among young HCV-infected injection drug users. Clinical Infectious Diseases, 40(Suppl 5), S304–S312.
   PubMed Web of Science ®Google Scholar
• Strauss, S. M., Astone-Twerell, J. M., Munoz-Plaza, C., Des Jarlais, D. C., Gwadz, M., Hagan, H., (2007). Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Services Research, 7, 39.
   PubMed Web of Science ®Google Scholar
• Tiffen, L., & Sheridan, S. (2002). Improving take-up of hepatitis C services. Nursing Times, 98(43), 30–32.
   PubMedGoogle Scholar
• Van den Berg, C. H., Smit, C., Bakker, M., Geskus, R. B., Berkhout, B., Jurriaans, S., (2007). Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users. European Journal of Epidemiology, 22(3), 183–193.
   PubMed Web of Science ®Google Scholar
• Williams, G. C., & Deci, E. L. (2001). Activating patients for smoking cessation through physician autonomy support. Medical Care, 39(8), 813–823.
   PubMed Web of Science ®Google Scholar
• Williams, G. C., Freedman, Z. R., & Deci, E. L. (1998). Supporting autonomy to motivate glucose control in patients with diabetes. Diabetes Care, 21, 1644–1651.
   PubMed Web of Science ®Google Scholar
• Williams, G. C., Gagné, M., Ryan, R. M., & Deci, E. L. (2002). Facilitating autonomous motivation for smoking cessation. Health Psychology, 21(1), 40–50.
   PubMed Web of Science ®Google Scholar
• Williams, G. C., McGregor, H., Sharp, D., Kouides, R. W., Lévesque, C. S., Ryan, R. M., (2006a). A self-determination multiple risk intervention trial to improve smokers’ health. Journal of General Internal Medicine, 21(12), 1288–1294.
   PubMed Web of Science ®Google Scholar
• Williams, G. C., McGregor, H. A., Sharp, D., Levesque, C., Kouides, R. W., Ryan, R. M., (2006b). Supporting autonomy and competence in a clinical trial. Health Psychology, 25(1), 91–101.
   PubMed Web of Science ®Google Scholar
• Zeuzem, S. (2004). Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: Who responds less well? Annals of Internal Medicine, 140(5), 370–381.
   PubMed Web of Science ®Google Scholar
• Zickmund, S. L., Bryce, C. L., Blasiole, J. A., Shinkunas, L., LaBrecque, D. R., & Arnold, R. M. (2006). Majority of patients with hepatitis C express physical, mental, and social difficulties with antiviral treatment. European Journal of Gastroenterology and Hepatology, 18(4), 381–388.
   PubMed Web of Science ®Google Scholar
• Zickmund, S. L., Ho, E. Y., Masuda, M., Ippolito, L., & LaBrecque, D. R. (2003). “They treated me like a leper.” Stigmatization and the quality of life of patients with hepatitis C. Journal of General Internal Medicine, 18(10), 835–844.
   PubMed Web of Science ®Google Scholar